Literature DB >> 18171385

Progress in Parkinson's disease.

A H Schapira.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171385     DOI: 10.1111/j.1468-1331.2007.02036.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  2 in total

1.  Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.

Authors:  Renata Pietsch Ribeiro; Eduardo Luiz Gasnhar Moreira; Danúbia Bonfanti Santos; Dirleise Colle; Alessandra Antunes Dos Santos; Kaite Cristiane Peres; Claudia Pinto Figueiredo; Marcelo Farina
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996

2.  Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice.

Authors:  Joanne Clark; Elizabeth L Clore; Kangni Zheng; Anthony Adame; Eliezer Masliah; David K Simon
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.